1 active not recruiting, 1 recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Rifampin-resistant Tuberculosis: new trials by email Literature Review of Rifampin-resistant Tuberculosis trials Research Report on Rifampin-resistant Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis Therapeutic Drug Monitoring for Linezolid - Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis | Not applicable | Recruiting | Albert Einstein College of Medicine | 280 | 2026-04-07 | 2026-05-04 |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort bedaquiline, delamanid, linezolid - Drug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Active not recruiting | Huashan Hospital | 120 | 2024-11-27 | 2025-09-02 |
Tuberculosis, Multidrug-Resistant (2) · Tuberculosis, Pulmonary (1)
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Mycobacterium Infections (2) · Tuberculosis (2) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Linezolid (2) · Clofazimine (1) · Fumigant 93 (1) · Levofloxacin (1) · OPC-67683 (1) · bedaquiline (1)
Albert Einstein College of Medicine (1) · Huashan Hospital (1)
China (1) · South Africa (1)
Gary Maartens, MBChB (1) · James CM Brust, MD (1)
R01AI184416 (1)